SCHEMBL6173716

SCHEMBL6173716

CC(c1ccnc(OCc2ccccc2)c1)C1(C(C)c2ccnc(OCc3ccccc3)c2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.46
GRM5 P41594 1/20 0.33
GRM3 Q14832 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174175 0.89 IGF1R (0.55) IGF1R
SCHEMBL6177313 0.87 IGF1R (0.45) IGF1R
SCHEMBL6174624 0.85 IGF1R (0.39) IGF1R
SCHEMBL6173711 0.85 IGF1R (0.59) IGF1R
SCHEMBL6172820 0.82 IGF1R (0.42) IGF1R
SCHEMBL6174494 0.82 IGF1R (0.42) IGF1R
SCHEMBL6175683 0.82 IGF1R (0.51) IGF1R
SCHEMBL6175155 0.81 IGF1R (0.55) IGF1R
SCHEMBL6174192 0.81 IGF1R (0.53) IGF1R
SCHEMBL6174011 0.81 IGF1R (0.56) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed